- Home
- REBN vs LSBPW Comparison
REBN vs LSBPW Comparison
Compare REBN & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- LSBPW
- Stock Information
- Founded
- REBN 2015
- LSBPW N/A
- Country
- REBN United States
- LSBPW China
- Employees
- REBN N/A
- LSBPW 758
- Industry
- REBN Restaurants
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- LSBPW Health Care
- Exchange
- REBN Nasdaq
- LSBPW Nasdaq
- Market Cap
- REBN 8.6M
- LSBPW N/A
- IPO Year
- REBN 2022
- LSBPW N/A
- Fundamental
- Price
- REBN $2.30
- LSBPW $0.07
- Analyst Decision
- REBN
- LSBPW
- Analyst Count
- REBN 0
- LSBPW 0
- Target Price
- REBN N/A
- LSBPW N/A
- AVG Volume (30 Days)
- REBN 24.3K
- LSBPW N/A
- Earning Date
- REBN 11-12-2024
- LSBPW N/A
- Dividend Yield
- REBN N/A
- LSBPW N/A
- EPS Growth
- REBN N/A
- LSBPW N/A
- EPS
- REBN N/A
- LSBPW N/A
- Revenue
- REBN $5,757,858.00
- LSBPW N/A
- Revenue This Year
- REBN $163.82
- LSBPW N/A
- Revenue Next Year
- REBN $64.55
- LSBPW N/A
- P/E Ratio
- REBN N/A
- LSBPW N/A
- Revenue Growth
- REBN 42.94
- LSBPW N/A
- 52 Week Low
- REBN $0.92
- LSBPW N/A
- 52 Week High
- REBN $8.80
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- REBN 31.36
- LSBPW N/A
- Support Level
- REBN $2.34
- LSBPW N/A
- Resistance Level
- REBN $2.87
- LSBPW N/A
- Average True Range (ATR)
- REBN 0.24
- LSBPW 0.00
- MACD
- REBN 0.00
- LSBPW 0.00
- Stochastic Oscillator
- REBN 21.22
- LSBPW 0.00
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.